Even though MAGEC2 is now known to play an important role in tumor progression, our study suggests that the up regulation of this gene in malignant TNBC is triggered by high extracellular Ca2+ and presumably, breast cancer-induced hypercalcemia in patients with advanced and metastasis-prone disease stages. The gene discussed is MAGEC2; the disease is hypercalcemia disease.